nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—SHBG—hindlimb—skin cancer	0.0219	0.214	CbGeAlD
Mitotane—FDX1—mammalian vulva—skin cancer	0.0121	0.119	CbGeAlD
Mitotane—FDX1—female reproductive system—skin cancer	0.0104	0.102	CbGeAlD
Mitotane—FDX1—head—skin cancer	0.00869	0.0849	CbGeAlD
Mitotane—SHBG—neck—skin cancer	0.00749	0.0732	CbGeAlD
Mitotane—CYP11A1—connective tissue—skin cancer	0.0067	0.0655	CbGeAlD
Mitotane—FDX1—lymph node—skin cancer	0.00608	0.0595	CbGeAlD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00538	0.00599	CcSEcCtD
Mitotane—SHBG—connective tissue—skin cancer	0.00537	0.0525	CbGeAlD
Mitotane—Speech disorder—Temozolomide—skin cancer	0.00534	0.00595	CcSEcCtD
Mitotane—Irritability—Imiquimod—skin cancer	0.00531	0.00592	CcSEcCtD
Mitotane—Nervous system disorder—Vismodegib—skin cancer	0.00509	0.00567	CcSEcCtD
Mitotane—Skin disorder—Vismodegib—skin cancer	0.00504	0.00562	CcSEcCtD
Mitotane—Breast disorder—Imiquimod—skin cancer	0.00503	0.0056	CcSEcCtD
Mitotane—Infestation NOS—Vemurafenib—skin cancer	0.00503	0.0056	CcSEcCtD
Mitotane—Infestation—Vemurafenib—skin cancer	0.00503	0.0056	CcSEcCtD
Mitotane—Speech disorder—Fluorouracil—skin cancer	0.00492	0.00548	CcSEcCtD
Mitotane—Hepatic enzyme increased—Temozolomide—skin cancer	0.00486	0.00541	CcSEcCtD
Mitotane—CYP11A1—female reproductive system—skin cancer	0.00472	0.0462	CbGeAlD
Mitotane—Dyspepsia—Vismodegib—skin cancer	0.00457	0.00509	CcSEcCtD
Mitotane—Decreased appetite—Vismodegib—skin cancer	0.00451	0.00503	CcSEcCtD
Mitotane—SERPINA6—female reproductive system—skin cancer	0.00449	0.0439	CbGeAlD
Mitotane—Gastrointestinal disorder—Vismodegib—skin cancer	0.00448	0.00499	CcSEcCtD
Mitotane—Dysarthria—Fluorouracil—skin cancer	0.00447	0.00498	CcSEcCtD
Mitotane—Pain—Vismodegib—skin cancer	0.00444	0.00494	CcSEcCtD
Mitotane—Connective tissue disorder—Vemurafenib—skin cancer	0.00443	0.00494	CcSEcCtD
Mitotane—Injury—Bleomycin—skin cancer	0.0043	0.00479	CcSEcCtD
Mitotane—Infestation NOS—Imiquimod—skin cancer	0.00429	0.00478	CcSEcCtD
Mitotane—Infestation—Imiquimod—skin cancer	0.00429	0.00478	CcSEcCtD
Mitotane—Eye disorder—Vemurafenib—skin cancer	0.00422	0.0047	CcSEcCtD
Mitotane—Neoplasm—Temozolomide—skin cancer	0.00415	0.00463	CcSEcCtD
Mitotane—Dermatitis atopic—Docetaxel—skin cancer	0.00413	0.0046	CcSEcCtD
Mitotane—Angiopathy—Vemurafenib—skin cancer	0.00409	0.00456	CcSEcCtD
Mitotane—Hepatobiliary disease—Imiquimod—skin cancer	0.00405	0.00452	CcSEcCtD
Mitotane—Mental disability—Temozolomide—skin cancer	0.00399	0.00444	CcSEcCtD
Mitotane—CYP11A1—head—skin cancer	0.00395	0.0386	CbGeAlD
Mitotane—Malnutrition—Vemurafenib—skin cancer	0.00393	0.00438	CcSEcCtD
Mitotane—Dysgeusia—Vemurafenib—skin cancer	0.00385	0.00429	CcSEcCtD
Mitotane—Urinary tract disorder—Imiquimod—skin cancer	0.0038	0.00423	CcSEcCtD
Mitotane—SHBG—female reproductive system—skin cancer	0.00379	0.037	CbGeAlD
Mitotane—Connective tissue disorder—Imiquimod—skin cancer	0.00378	0.00421	CcSEcCtD
Mitotane—Urethral disorder—Imiquimod—skin cancer	0.00377	0.0042	CcSEcCtD
Mitotane—Lethargy—Dactinomycin—skin cancer	0.00376	0.00419	CcSEcCtD
Mitotane—SERPINA6—head—skin cancer	0.00375	0.0367	CbGeAlD
Mitotane—Asthenia—Vismodegib—skin cancer	0.00372	0.00415	CcSEcCtD
Mitotane—Visual impairment—Imiquimod—skin cancer	0.00371	0.00413	CcSEcCtD
Mitotane—Eye disorder—Imiquimod—skin cancer	0.0036	0.00401	CcSEcCtD
Mitotane—Flushing—Imiquimod—skin cancer	0.00357	0.00398	CcSEcCtD
Mitotane—Diarrhoea—Vismodegib—skin cancer	0.00355	0.00396	CcSEcCtD
Mitotane—Amnesia—Temozolomide—skin cancer	0.00355	0.00395	CcSEcCtD
Mitotane—Angiopathy—Imiquimod—skin cancer	0.00349	0.00389	CcSEcCtD
Mitotane—Mental disorder—Imiquimod—skin cancer	0.00337	0.00376	CcSEcCtD
Mitotane—Malnutrition—Imiquimod—skin cancer	0.00335	0.00373	CcSEcCtD
Mitotane—Diplopia—Temozolomide—skin cancer	0.00333	0.00371	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00332	0.0037	CcSEcCtD
Mitotane—Vomiting—Vismodegib—skin cancer	0.0033	0.00368	CcSEcCtD
Mitotane—Rash—Vismodegib—skin cancer	0.00327	0.00365	CcSEcCtD
Mitotane—Amnesia—Fluorouracil—skin cancer	0.00327	0.00364	CcSEcCtD
Mitotane—Dermatitis—Vismodegib—skin cancer	0.00327	0.00364	CcSEcCtD
Mitotane—Infection—Vemurafenib—skin cancer	0.00319	0.00355	CcSEcCtD
Mitotane—Nervous system disorder—Vemurafenib—skin cancer	0.00314	0.0035	CcSEcCtD
Mitotane—Ataxia—Temozolomide—skin cancer	0.00314	0.00349	CcSEcCtD
Mitotane—Lethargy—Fluorouracil—skin cancer	0.00313	0.00349	CcSEcCtD
Mitotane—Skin disorder—Vemurafenib—skin cancer	0.00311	0.00347	CcSEcCtD
Mitotane—Nausea—Vismodegib—skin cancer	0.00308	0.00343	CcSEcCtD
Mitotane—Osteoarthritis—Fluorouracil—skin cancer	0.00307	0.00342	CcSEcCtD
Mitotane—Hepatocellular injury—Docetaxel—skin cancer	0.00305	0.0034	CcSEcCtD
Mitotane—Breast disorder—Temozolomide—skin cancer	0.00301	0.00336	CcSEcCtD
Mitotane—Hypotension—Vemurafenib—skin cancer	0.003	0.00334	CcSEcCtD
Mitotane—Neutropenia—Dactinomycin—skin cancer	0.00298	0.00332	CcSEcCtD
Mitotane—Muscular weakness—Temozolomide—skin cancer	0.00294	0.00328	CcSEcCtD
Mitotane—Irritability—Fluorouracil—skin cancer	0.00293	0.00327	CcSEcCtD
Mitotane—Haematuria—Bleomycin—skin cancer	0.0029	0.00324	CcSEcCtD
Mitotane—Hypertension—Imiquimod—skin cancer	0.00289	0.00322	CcSEcCtD
Mitotane—Ataxia—Fluorouracil—skin cancer	0.00289	0.00322	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00283	0.00316	CcSEcCtD
Mitotane—Decreased appetite—Vemurafenib—skin cancer	0.00279	0.0031	CcSEcCtD
Mitotane—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00277	0.00308	CcSEcCtD
Mitotane—CYP11A1—lymph node—skin cancer	0.00276	0.027	CbGeAlD
Mitotane—Neoplasm—Docetaxel—skin cancer	0.00276	0.00308	CcSEcCtD
Mitotane—Infection—Imiquimod—skin cancer	0.00272	0.00303	CcSEcCtD
Mitotane—Muscular weakness—Fluorouracil—skin cancer	0.00271	0.00302	CcSEcCtD
Mitotane—Neutropenia—Temozolomide—skin cancer	0.00269	0.003	CcSEcCtD
Mitotane—Shock—Imiquimod—skin cancer	0.00269	0.003	CcSEcCtD
Mitotane—Nervous system disorder—Imiquimod—skin cancer	0.00268	0.00299	CcSEcCtD
Mitotane—Skin disorder—Imiquimod—skin cancer	0.00266	0.00296	CcSEcCtD
Mitotane—Anorexia—Imiquimod—skin cancer	0.00261	0.0029	CcSEcCtD
Mitotane—Infestation NOS—Temozolomide—skin cancer	0.00257	0.00286	CcSEcCtD
Mitotane—Infestation—Temozolomide—skin cancer	0.00257	0.00286	CcSEcCtD
Mitotane—Hepatitis—Dactinomycin—skin cancer	0.00255	0.00284	CcSEcCtD
Mitotane—Flushing—Bleomycin—skin cancer	0.00254	0.00283	CcSEcCtD
Mitotane—Body temperature increased—Vemurafenib—skin cancer	0.00253	0.00282	CcSEcCtD
Mitotane—Paraesthesia—Imiquimod—skin cancer	0.00246	0.00274	CcSEcCtD
Mitotane—Somnolence—Imiquimod—skin cancer	0.00243	0.00271	CcSEcCtD
Mitotane—Hepatobiliary disease—Temozolomide—skin cancer	0.00243	0.00271	CcSEcCtD
Mitotane—Dyspepsia—Imiquimod—skin cancer	0.00241	0.00268	CcSEcCtD
Mitotane—Decreased appetite—Imiquimod—skin cancer	0.00238	0.00265	CcSEcCtD
Mitotane—Infestation NOS—Fluorouracil—skin cancer	0.00237	0.00264	CcSEcCtD
Mitotane—Infestation—Fluorouracil—skin cancer	0.00237	0.00264	CcSEcCtD
Mitotane—Flushing—Dactinomycin—skin cancer	0.00237	0.00264	CcSEcCtD
Mitotane—Hypersensitivity—Vemurafenib—skin cancer	0.00236	0.00263	CcSEcCtD
Mitotane—Gastrointestinal disorder—Imiquimod—skin cancer	0.00236	0.00263	CcSEcCtD
Mitotane—Pain—Imiquimod—skin cancer	0.00234	0.0026	CcSEcCtD
Mitotane—Hepatitis—Temozolomide—skin cancer	0.00231	0.00257	CcSEcCtD
Mitotane—Asthenia—Vemurafenib—skin cancer	0.0023	0.00256	CcSEcCtD
Mitotane—Urinary tract disorder—Temozolomide—skin cancer	0.00228	0.00254	CcSEcCtD
Mitotane—Connective tissue disorder—Temozolomide—skin cancer	0.00227	0.00252	CcSEcCtD
Mitotane—Lethargy—Docetaxel—skin cancer	0.00226	0.00252	CcSEcCtD
Mitotane—Urethral disorder—Temozolomide—skin cancer	0.00226	0.00252	CcSEcCtD
Mitotane—Feeling abnormal—Imiquimod—skin cancer	0.00225	0.00251	CcSEcCtD
Mitotane—Visual impairment—Temozolomide—skin cancer	0.00222	0.00248	CcSEcCtD
Mitotane—Anaemia—Bleomycin—skin cancer	0.0022	0.00245	CcSEcCtD
Mitotane—Diarrhoea—Vemurafenib—skin cancer	0.00219	0.00244	CcSEcCtD
Mitotane—Body temperature increased—Imiquimod—skin cancer	0.00216	0.00241	CcSEcCtD
Mitotane—Eye disorder—Temozolomide—skin cancer	0.00216	0.0024	CcSEcCtD
Mitotane—Flushing—Temozolomide—skin cancer	0.00214	0.00238	CcSEcCtD
Mitotane—Dizziness—Vemurafenib—skin cancer	0.00212	0.00236	CcSEcCtD
Mitotane—Angiopathy—Temozolomide—skin cancer	0.00209	0.00233	CcSEcCtD
Mitotane—Ataxia—Docetaxel—skin cancer	0.00208	0.00232	CcSEcCtD
Mitotane—Anaemia—Dactinomycin—skin cancer	0.00205	0.00229	CcSEcCtD
Mitotane—Vomiting—Vemurafenib—skin cancer	0.00204	0.00227	CcSEcCtD
Mitotane—Orthostatic hypotension—Docetaxel—skin cancer	0.00203	0.00226	CcSEcCtD
Mitotane—Rash—Vemurafenib—skin cancer	0.00202	0.00225	CcSEcCtD
Mitotane—Mental disorder—Temozolomide—skin cancer	0.00202	0.00225	CcSEcCtD
Mitotane—Dermatitis—Vemurafenib—skin cancer	0.00202	0.00225	CcSEcCtD
Mitotane—Hypersensitivity—Imiquimod—skin cancer	0.00201	0.00224	CcSEcCtD
Mitotane—Headache—Vemurafenib—skin cancer	0.00201	0.00224	CcSEcCtD
Mitotane—Malnutrition—Temozolomide—skin cancer	0.00201	0.00224	CcSEcCtD
Mitotane—Breast disorder—Docetaxel—skin cancer	0.002	0.00223	CcSEcCtD
Mitotane—Dysgeusia—Temozolomide—skin cancer	0.00197	0.00219	CcSEcCtD
Mitotane—Asthenia—Imiquimod—skin cancer	0.00196	0.00219	CcSEcCtD
Mitotane—Confusional state—Bleomycin—skin cancer	0.00196	0.00218	CcSEcCtD
Mitotane—Infection—Bleomycin—skin cancer	0.00193	0.00215	CcSEcCtD
Mitotane—Nausea—Vemurafenib—skin cancer	0.0019	0.00212	CcSEcCtD
Mitotane—Thrombocytopenia—Bleomycin—skin cancer	0.0019	0.00212	CcSEcCtD
Mitotane—Vision blurred—Temozolomide—skin cancer	0.00189	0.00211	CcSEcCtD
Mitotane—Tremor—Temozolomide—skin cancer	0.00188	0.0021	CcSEcCtD
Mitotane—Diarrhoea—Imiquimod—skin cancer	0.00187	0.00208	CcSEcCtD
Mitotane—Anaemia—Temozolomide—skin cancer	0.00186	0.00207	CcSEcCtD
Mitotane—Anorexia—Bleomycin—skin cancer	0.00185	0.00206	CcSEcCtD
Mitotane—Hypotension—Bleomycin—skin cancer	0.00182	0.00202	CcSEcCtD
Mitotane—Dizziness—Imiquimod—skin cancer	0.00181	0.00201	CcSEcCtD
Mitotane—Vertigo—Temozolomide—skin cancer	0.0018	0.00201	CcSEcCtD
Mitotane—Infection—Dactinomycin—skin cancer	0.0018	0.002	CcSEcCtD
Mitotane—Neutropenia—Docetaxel—skin cancer	0.00179	0.002	CcSEcCtD
Mitotane—Thrombocytopenia—Dactinomycin—skin cancer	0.00177	0.00198	CcSEcCtD
Mitotane—Paraesthesia—Bleomycin—skin cancer	0.00174	0.00194	CcSEcCtD
Mitotane—Vision blurred—Fluorouracil—skin cancer	0.00174	0.00194	CcSEcCtD
Mitotane—Vomiting—Imiquimod—skin cancer	0.00174	0.00194	CcSEcCtD
Mitotane—Hypertension—Temozolomide—skin cancer	0.00173	0.00193	CcSEcCtD
Mitotane—Anorexia—Dactinomycin—skin cancer	0.00173	0.00192	CcSEcCtD
Mitotane—Rash—Imiquimod—skin cancer	0.00172	0.00192	CcSEcCtD
Mitotane—Dermatitis—Imiquimod—skin cancer	0.00172	0.00192	CcSEcCtD
Mitotane—Headache—Imiquimod—skin cancer	0.00171	0.00191	CcSEcCtD
Mitotane—Anaemia—Fluorouracil—skin cancer	0.00171	0.0019	CcSEcCtD
Mitotane—Infestation NOS—Docetaxel—skin cancer	0.00171	0.0019	CcSEcCtD
Mitotane—Infestation—Docetaxel—skin cancer	0.00171	0.0019	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.0017	0.00189	CcSEcCtD
Mitotane—Decreased appetite—Bleomycin—skin cancer	0.00169	0.00188	CcSEcCtD
Mitotane—Pain—Bleomycin—skin cancer	0.00166	0.00185	CcSEcCtD
Mitotane—Confusional state—Temozolomide—skin cancer	0.00165	0.00184	CcSEcCtD
Mitotane—Infection—Temozolomide—skin cancer	0.00163	0.00181	CcSEcCtD
Mitotane—Nausea—Imiquimod—skin cancer	0.00162	0.00181	CcSEcCtD
Mitotane—Hepatobiliary disease—Docetaxel—skin cancer	0.00162	0.0018	CcSEcCtD
Mitotane—Nervous system disorder—Temozolomide—skin cancer	0.00161	0.00179	CcSEcCtD
Mitotane—Thrombocytopenia—Temozolomide—skin cancer	0.0016	0.00179	CcSEcCtD
Mitotane—Feeling abnormal—Bleomycin—skin cancer	0.0016	0.00178	CcSEcCtD
Mitotane—Skin disorder—Temozolomide—skin cancer	0.00159	0.00177	CcSEcCtD
Mitotane—Decreased appetite—Dactinomycin—skin cancer	0.00157	0.00175	CcSEcCtD
Mitotane—Anorexia—Temozolomide—skin cancer	0.00156	0.00174	CcSEcCtD
Mitotane—Pain—Dactinomycin—skin cancer	0.00155	0.00173	CcSEcCtD
Mitotane—Body temperature increased—Bleomycin—skin cancer	0.00154	0.00171	CcSEcCtD
Mitotane—Hepatitis—Docetaxel—skin cancer	0.00153	0.00171	CcSEcCtD
Mitotane—Confusional state—Fluorouracil—skin cancer	0.00152	0.0017	CcSEcCtD
Mitotane—Urinary tract disorder—Docetaxel—skin cancer	0.00151	0.00169	CcSEcCtD
Mitotane—Connective tissue disorder—Docetaxel—skin cancer	0.00151	0.00168	CcSEcCtD
Mitotane—Urethral disorder—Docetaxel—skin cancer	0.0015	0.00167	CcSEcCtD
Mitotane—Infection—Fluorouracil—skin cancer	0.0015	0.00167	CcSEcCtD
Mitotane—Feeling abnormal—Dactinomycin—skin cancer	0.00149	0.00166	CcSEcCtD
Mitotane—Nervous system disorder—Fluorouracil—skin cancer	0.00148	0.00165	CcSEcCtD
Mitotane—Thrombocytopenia—Fluorouracil—skin cancer	0.00148	0.00165	CcSEcCtD
Mitotane—Visual impairment—Docetaxel—skin cancer	0.00148	0.00165	CcSEcCtD
Mitotane—Paraesthesia—Temozolomide—skin cancer	0.00147	0.00164	CcSEcCtD
Mitotane—Somnolence—Temozolomide—skin cancer	0.00146	0.00162	CcSEcCtD
Mitotane—Dyspepsia—Temozolomide—skin cancer	0.00144	0.00161	CcSEcCtD
Mitotane—Anorexia—Fluorouracil—skin cancer	0.00144	0.0016	CcSEcCtD
Mitotane—Eye disorder—Docetaxel—skin cancer	0.00143	0.0016	CcSEcCtD
Mitotane—Body temperature increased—Dactinomycin—skin cancer	0.00143	0.0016	CcSEcCtD
Mitotane—Hypersensitivity—Bleomycin—skin cancer	0.00143	0.00159	CcSEcCtD
Mitotane—Decreased appetite—Temozolomide—skin cancer	0.00142	0.00159	CcSEcCtD
Mitotane—Flushing—Docetaxel—skin cancer	0.00142	0.00159	CcSEcCtD
Mitotane—Gastrointestinal disorder—Temozolomide—skin cancer	0.00141	0.00158	CcSEcCtD
Mitotane—Hypotension—Fluorouracil—skin cancer	0.00141	0.00157	CcSEcCtD
Mitotane—Pain—Temozolomide—skin cancer	0.0014	0.00156	CcSEcCtD
Mitotane—Asthenia—Bleomycin—skin cancer	0.00139	0.00155	CcSEcCtD
Mitotane—Angiopathy—Docetaxel—skin cancer	0.00139	0.00155	CcSEcCtD
Mitotane—Paraesthesia—Fluorouracil—skin cancer	0.00136	0.00151	CcSEcCtD
Mitotane—Feeling abnormal—Temozolomide—skin cancer	0.00135	0.0015	CcSEcCtD
Mitotane—Mental disorder—Docetaxel—skin cancer	0.00134	0.0015	CcSEcCtD
Mitotane—Somnolence—Fluorouracil—skin cancer	0.00134	0.0015	CcSEcCtD
Mitotane—Malnutrition—Docetaxel—skin cancer	0.00134	0.00149	CcSEcCtD
Mitotane—Hypersensitivity—Dactinomycin—skin cancer	0.00133	0.00149	CcSEcCtD
Mitotane—Dyspepsia—Fluorouracil—skin cancer	0.00133	0.00148	CcSEcCtD
Mitotane—Decreased appetite—Fluorouracil—skin cancer	0.00131	0.00146	CcSEcCtD
Mitotane—Dysgeusia—Docetaxel—skin cancer	0.00131	0.00146	CcSEcCtD
Mitotane—Gastrointestinal disorder—Fluorouracil—skin cancer	0.0013	0.00145	CcSEcCtD
Mitotane—Asthenia—Dactinomycin—skin cancer	0.0013	0.00145	CcSEcCtD
Mitotane—Body temperature increased—Temozolomide—skin cancer	0.0013	0.00144	CcSEcCtD
Mitotane—Pain—Fluorouracil—skin cancer	0.00129	0.00144	CcSEcCtD
Mitotane—Feeling abnormal—Fluorouracil—skin cancer	0.00124	0.00139	CcSEcCtD
Mitotane—Diarrhoea—Dactinomycin—skin cancer	0.00124	0.00138	CcSEcCtD
Mitotane—Vomiting—Bleomycin—skin cancer	0.00124	0.00138	CcSEcCtD
Mitotane—Anaemia—Docetaxel—skin cancer	0.00123	0.00137	CcSEcCtD
Mitotane—Rash—Bleomycin—skin cancer	0.00122	0.00136	CcSEcCtD
Mitotane—Dermatitis—Bleomycin—skin cancer	0.00122	0.00136	CcSEcCtD
Mitotane—Hypersensitivity—Temozolomide—skin cancer	0.00121	0.00134	CcSEcCtD
Mitotane—Body temperature increased—Fluorouracil—skin cancer	0.00119	0.00133	CcSEcCtD
Mitotane—Asthenia—Temozolomide—skin cancer	0.00118	0.00131	CcSEcCtD
Mitotane—Nausea—Bleomycin—skin cancer	0.00115	0.00129	CcSEcCtD
Mitotane—Hypertension—Docetaxel—skin cancer	0.00115	0.00128	CcSEcCtD
Mitotane—Vomiting—Dactinomycin—skin cancer	0.00115	0.00128	CcSEcCtD
Mitotane—Rash—Dactinomycin—skin cancer	0.00114	0.00127	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00113	0.00126	CcSEcCtD
Mitotane—Diarrhoea—Temozolomide—skin cancer	0.00112	0.00125	CcSEcCtD
Mitotane—Hypersensitivity—Fluorouracil—skin cancer	0.00111	0.00124	CcSEcCtD
Mitotane—Confusional state—Docetaxel—skin cancer	0.0011	0.00122	CcSEcCtD
Mitotane—Dizziness—Temozolomide—skin cancer	0.00108	0.00121	CcSEcCtD
Mitotane—Infection—Docetaxel—skin cancer	0.00108	0.00121	CcSEcCtD
Mitotane—Nausea—Dactinomycin—skin cancer	0.00108	0.0012	CcSEcCtD
Mitotane—Shock—Docetaxel—skin cancer	0.00107	0.00119	CcSEcCtD
Mitotane—Nervous system disorder—Docetaxel—skin cancer	0.00107	0.00119	CcSEcCtD
Mitotane—Thrombocytopenia—Docetaxel—skin cancer	0.00107	0.00119	CcSEcCtD
Mitotane—Skin disorder—Docetaxel—skin cancer	0.00106	0.00118	CcSEcCtD
Mitotane—Vomiting—Temozolomide—skin cancer	0.00104	0.00116	CcSEcCtD
Mitotane—Anorexia—Docetaxel—skin cancer	0.00104	0.00116	CcSEcCtD
Mitotane—Rash—Temozolomide—skin cancer	0.00103	0.00115	CcSEcCtD
Mitotane—Diarrhoea—Fluorouracil—skin cancer	0.00103	0.00115	CcSEcCtD
Mitotane—Dermatitis—Temozolomide—skin cancer	0.00103	0.00115	CcSEcCtD
Mitotane—Headache—Temozolomide—skin cancer	0.00103	0.00114	CcSEcCtD
Mitotane—Hypotension—Docetaxel—skin cancer	0.00102	0.00113	CcSEcCtD
Mitotane—Dizziness—Fluorouracil—skin cancer	0.000998	0.00111	CcSEcCtD
Mitotane—Paraesthesia—Docetaxel—skin cancer	0.000979	0.00109	CcSEcCtD
Mitotane—Nausea—Temozolomide—skin cancer	0.000973	0.00108	CcSEcCtD
Mitotane—Somnolence—Docetaxel—skin cancer	0.000969	0.00108	CcSEcCtD
Mitotane—Vomiting—Fluorouracil—skin cancer	0.00096	0.00107	CcSEcCtD
Mitotane—Dyspepsia—Docetaxel—skin cancer	0.000959	0.00107	CcSEcCtD
Mitotane—Rash—Fluorouracil—skin cancer	0.000952	0.00106	CcSEcCtD
Mitotane—Dermatitis—Fluorouracil—skin cancer	0.000951	0.00106	CcSEcCtD
Mitotane—Decreased appetite—Docetaxel—skin cancer	0.000947	0.00106	CcSEcCtD
Mitotane—Headache—Fluorouracil—skin cancer	0.000946	0.00105	CcSEcCtD
Mitotane—Gastrointestinal disorder—Docetaxel—skin cancer	0.000941	0.00105	CcSEcCtD
Mitotane—Pain—Docetaxel—skin cancer	0.000932	0.00104	CcSEcCtD
Mitotane—Feeling abnormal—Docetaxel—skin cancer	0.000898	0.001	CcSEcCtD
Mitotane—Nausea—Fluorouracil—skin cancer	0.000897	0.000999	CcSEcCtD
Mitotane—Body temperature increased—Docetaxel—skin cancer	0.000861	0.00096	CcSEcCtD
Mitotane—Hypersensitivity—Docetaxel—skin cancer	0.000803	0.000894	CcSEcCtD
Mitotane—Asthenia—Docetaxel—skin cancer	0.000782	0.000871	CcSEcCtD
Mitotane—Diarrhoea—Docetaxel—skin cancer	0.000746	0.000831	CcSEcCtD
Mitotane—Dizziness—Docetaxel—skin cancer	0.000721	0.000803	CcSEcCtD
Mitotane—Vomiting—Docetaxel—skin cancer	0.000693	0.000772	CcSEcCtD
Mitotane—Rash—Docetaxel—skin cancer	0.000687	0.000765	CcSEcCtD
Mitotane—Dermatitis—Docetaxel—skin cancer	0.000686	0.000765	CcSEcCtD
Mitotane—Headache—Docetaxel—skin cancer	0.000683	0.00076	CcSEcCtD
Mitotane—Nausea—Docetaxel—skin cancer	0.000647	0.000721	CcSEcCtD
